Page 59 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

Swallowing function after treatment for early-stage OPC
REFERENCES
1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-9.
2. Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-- systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747-55.
3. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94(11):2967-80.
4. de Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096-102.
5. Morisod B, Simon C. Meta-analysis on survival of patients treated with transoral surgery versus radiotherapy for early-stage squamous cell carcinoma of the oropharynx. Head Neck. 2016;38 Suppl 1:E2143-50.
6. Evans M, Jones TM. Transoral Surgery or Radiotherapy for Oropharyngeal Carcinoma - Is It Either Or...? Clin Oncol (R Coll Radiol). 2016;28(7):413- 20.
7. Howard J, Masterson L, Dwivedi RC, et al. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma. Cochrane Database Syst Rev. 2016;12:Cd010963.
8. Turner MT, Byrd JK, Ferris RL. Current Role of Surgery in the Management of Oropharyngeal Cancer. J Oncol Pract. 2016;12(11):1176-83.
9. Huang SH, Hahn E, Tsang RK, Chen ZJ, O’Sullivan B. The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: Getting
the balance right. Oral Oncol. 2018;86:171-80.
10. Sinha P, Karadaghy OA, Doering MM, et al. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical
treatment approach: A systematic review and meta-analysis. Oral Oncol. 2018;86:121-31.
11. Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell
carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2019.
12. Nichols AC, Yoo J, Hammond JA, et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery
(ORATOR)--study protocol for a randomized phase II trial. BMC Cancer. 2013;13:133.
13. Maggiore RJ, Curran EK, Witt ME, et al. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with
chemoradiation therapy. J Geriatr Oncol. 2013;4(4):327-33.
14. Hutcheson KA, Lewin JS, Barringer DA, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer.
2012;118(23):5793-9.
15. Roe JW, Drinnan MJ, Carding PN, Harrington KJ, Nutting CM. Patient-reported outcomes following parotid-sparing intensity-modulated
radiotherapy for head and neck cancer. How important is dysphagia? Oral oncology. 2014;50(12):1182-7.
16. Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and neck cancer treatment: patients’perspectives. Otolaryngol Head Neck
Surg. 2011;145(5):767-71.
17. Ness AR, Waylen A, Hurley K, et al. Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource:
head and neck 5000. BMC Cancer. 2014;14:973.
18. Ness AR, Waylen A, Hurley K, et al. Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study:
head and neck 5000. Clin Otolaryngol. 2016;41(6):804-9.
19. National Clinical Analysis and Specialised Applications Team, NHS. National Radiotherapy Dataset. http://www.natcansat.nhs.uk/rt/rtdsaspx.
2017.
20. National Institute for Health and Care Excellence (NICE). Alcohol-use disorders: preventing harmful drinking. Available from: https://www.nice.
org.uk/guidance/ph24/resources/alcoholuse-disorders-prevention-pdf-1996237007557 2010.
21. Department for Communities and Local Government. https://www.gov.uk/government/collections/english-indices-of-deprivation. 2012.
22. Medicine WUSo. Adult Comorbidity Evaluation-27 (Washington University School of Medicine). https://www.rtog.org/
LinkClickaspx?fileticket=oClaTCMufRA%3D&tabid=290. 2003.
23. Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion
proteins. Clin Chem. 2005;51(10):1845-53.
24. Sherman AC, Simonton S, Adams DC, et al. Assessing quality of life in patients with head and neck cancer: cross-validation of the European
Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Archives of otolaryngology--
head & neck surgery. 2000;126(4):459-67.
25. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-6.
26. Dziegielewski PT, Teknos TN, Durmus K, et al. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.
JAMA Otolaryngol Head Neck Surg. 2013;139(11):1099-108.
27. Sethia R, Yumusakhuylu AC, Ozbay I, et al. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal
cancer. Laryngoscope. 2018;128(2):403-11.
28. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review. Eur Arch Otorhinolaryngol. 2015;272(2):463-71.
2
57